J&J, Pfizer, Others Beat Pharmacies' Drug Pricing Suit

Law360, Washington (August 16, 2012, 7:46 PM EDT) -- A New York federal judge on Thursday tossed a long-running drug price discrimination suit against Abbott Laboratories, Johnson & Johnson, Pfizer Inc. and other top drugmakers, saying the more than 700 pharmacy plaintiffs had failed to show they were harmed by the allegedly anti-competitive practices.

U.S. Magistrate Judge Steven M. Gold determined that the individually owned retail pharmacies couldn't prove that they had lost a significant portion of their clientele to favored drug purchasers due to the brand name drugmakers refusing to sell directly to the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.